Obagi NU Derm System

Transform the look of your skin with the Obagi Nu-Derm® System. Factors such as sun exposure and genetics contribute to photoaging, which results in premature ageing of the skin.

Obagi Nu-Derm® is the #1 physician-dispensed skin care system specifically formulated for all skin types.

This hyperpigmentation system contains prescription 4% hydroquinone to correct hyperpigmentation and help restore younger, healthier-looking skin.

The Obagi Nu-Derm® System plus tretinoin* helps to improve these signs of visible skin ageing: • Hyperpigmentation and sunspots • Rough, uneven skin • Unwanted lax or loose-looking skin • Appearance of fine lines and wrinkles


Important Safety Information for Clear and Blender (contain 4% hydroquinone)

CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, the patient should rinse eyes, nose, mouth, or lips with water and contact physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS): Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment. Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother. Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established. Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted. Please see accompanying full Prescribing Information.

INDICATION Tretinoin Cream (0.1%, 0.05% and 0.025%) are used in the topical treatment of acne vulgaris. Tretinoin is for use on the skin only. Do not get it in your mouth, eyes, vagina or the corners of your nose.

IMPORTANT SAFETY INFORMATION While using tretinoin, you should: • minimise exposure to the sun and to extreme cold or wind. Avoid sunlamps, tanning beds and ultraviolet light • use a sunscreen with an SPF of at least 15, wear protective clothing and wide-brimmed hat • stop using tretinoin if you get a sunburn • to avoid washing your skin too often, scrubbing the affected skin, or using other products with a drying effect, including other products containing tretinoin, unless recommended by your practitioner Before using tretinoin, tell your practitioner if you: • have a skin condition called eczema • have a sunburn • are pregnant or breastfeeding, think you are pregnant or plan to become pregnant or to breastfeed What are the possible side effects of tretinoin? • skin dryness, burning, redness, excessive aking or peeling. If you develop these symptoms your practitioner may tell you to stop using it for a while, decrease the number of applications, or stop using it completely. Tell your practitioner about any side effect that bothers you or does not go away.

The safety and efficacy of tretinoin have not been established in the treatment of patients younger than 12 years of age or in pregnant or nursing women.